Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies.
about
Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patientsSerum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression.Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysisManagement and prognosis of atrial fibrillation in the diabetic patient.Association between insomnia and atrial fibrillation in a Chinese population: A cross-sectional study.Lifestyle management to prevent and treat atrial fibrillation.Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study.Diabetes and new-onset atrial fibrillation in a hypertensive population.Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetesPioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits.Reactive oxygen species mediated oxidative stress links diabetes and atrial fibrillation.Role of CHA2DS2-VASc score in predicting new-onset atrial fibrillation in patients with type 2 diabetes mellitus with and without hyperosmolar hyperglycaemic state: real-world data from a nationwide cohort.Risk Factor Management in Atrial Fibrillation.Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress-Mediated Atrial Remodeling in Alloxan-Induced Diabetes Mellitus Rabbits.Inflammation and atrial fibrillation: A comprehensive reviewAUTOMATED DIAGNOSIS OF DIABETES USING ENTROPIES AND DIABETIC INDEX
P2860
Q33592535-602D840E-A699-4D82-BB59-5BF93E7F5E95Q36299330-F9D009BE-FFAF-4D7A-88CC-B48C7F763520Q36337187-653E8AC2-F343-4F38-9EDC-A29E69150CAAQ38497702-69B37430-B41F-4920-B276-5C3CACB7881FQ38754373-EAC717F2-A494-447A-B01E-3A77DA60EFFCQ38817182-C7625B67-9B9F-4FB1-B1E7-9E824D23E6F8Q39061640-91C1B46F-B265-43A1-9FED-C1AA247B61C1Q40873653-FBFD5DFC-4A45-47BD-92F3-624540CB444CQ42368137-4E9B14AB-5951-462E-BDAA-6D4A253E1E39Q48194292-D253C1F4-F0D9-4948-9E7A-ECDE33C13A66Q49379427-ABF4F1D8-8BB5-4548-AEAB-3DBFA6AB86CAQ52641851-496F5531-04F2-4463-9A54-C12124FBB921Q55411533-5B0C5787-D659-4404-854A-F0072AF3E97CQ55499271-3C1FCEE3-C0D0-4D6D-AAF1-53AE3EBA6191Q57179188-0393CDD9-D2B9-4CDE-9DC5-9BF9A72C5974Q57558251-EF45D2FF-FF89-4D66-83A4-C16A84E0C5EE
P2860
Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Diabetes mellitus and atrial f ...... potential upstream therapies.
@en
type
label
Diabetes mellitus and atrial f ...... potential upstream therapies.
@en
prefLabel
Diabetes mellitus and atrial f ...... potential upstream therapies.
@en
P2093
P1476
Diabetes mellitus and atrial f ...... potential upstream therapies.
@en
P2093
Christos A Goudis
Dimitrios G Ketikoglou
Eleftherios M Kallergis
Ioannis V Ntalas
Panagiotis Korantzopoulos
P304
P356
10.1016/J.IJCARD.2015.03.052
P407
P577
2015-03-05T00:00:00Z